EcoDrugPlus

Cyclin-Dependent Kinase 7

Ensembl ID : ENSCING00000002325
Gene Symbol: LOC100182642
4 Cross references
219 Possible Orthologues:

Cyclin-Dependent Kinase 9

Ensembl ID : ENSCING00000008843
Gene Symbol: LOC100181821
4 Cross references
208 Possible Orthologues:

Delta(24)-Sterol Reductase-Like

Ensembl ID : ENSCING00000008369
Gene Symbol: LOC100181233
4 Cross references
209 Possible Orthologues:

Dipeptidyl Peptidase 1-Like

Ensembl ID : ENSCING00000007400
Gene Symbol: LOC104266675
4 Cross references
239 Possible Orthologues:

Dual Specificity Protein Kinase Ttk-Like

Ensembl ID : ENSCING00000004929
Gene Symbol: LOC100176899
4 Cross references
205 Possible Orthologues:

Egl Nine Homolog 1

Ensembl ID : ENSCING00000001903
Gene Symbol: LOC100180463
4 Cross references
256 Possible Orthologues:

Exportin-1

Ensembl ID : ENSCING00000024562
Gene Symbol: LOC100184417
4 Cross references
300 Possible Orthologues:

Fibroblast Growth Factor Receptor

Ensembl ID : ENSCING00000000875
Gene Symbol: FGFR
4 Cross references
295 Possible Orthologues:

Fibroblast Growth Factor Receptor-Like

Ensembl ID : ENSCING00000024641
Gene Symbol: LOC100178753
3 Cross references
222 Possible Orthologues:

Folate Receptor Gamma

Ensembl ID : ENSCING00000005953
Gene Symbol: LOC100178291
4 Cross references
432 Possible Orthologues:

Folate Receptor Gamma-Like

Ensembl ID : ENSCING00000012209
Gene Symbol: LOC100183675
4 Cross references
432 Possible Orthologues:

Fta Protein

Ensembl ID : ENSCING00000006149
Gene Symbol: FTA
4 Cross references
222 Possible Orthologues:

Select Keywords:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).